En español

NIDA Announces 2012 Avant-Garde Award for Medications Development

July 18, 2012

NIDA’s Dr. Nora D. Volkow will announce the winner of the 2012 Avant-Garde Award for Medications Development during the XIX International AIDS Conference in Washington, DC. This research competition, now in its third year, is intended to stimulate high-impact research that may lead to groundbreaking opportunities for the prevention and treatment of drug abuse. This year’s winner will receive $1,000,000 per year for five years in research support.

WHO: Dr. Nora D. Volkow, Director, National Institute on Drug Abuse (NIDA)

WHAT: NIDA’s 2012 Avant-Garde Award for Medications Development

WHEN: Wednesday, July 25, 2012, 4:00 p.m. EDT

WHERE: XIX International AIDS Conference
Walter E. Washington Convention Center (WCC)
Media Center – Hall A, Lower Level, Press Conference Room 3 (PCR 3)*

*Access to the Media Centre is strictly limited to accredited journalists.

Dr. Volkow will also speak at the “New Frontiers in NIH AIDS Research” satellite session on Sunday, July 22 from 11:15 a.m. – 1:15 p.m. EDT in Session Room 6 of the WCC.

For more information, or to arrange an interview with Dr. Volkow, please contact NIDA’s press team: media@nida.nih.gov or 301-443-6245. Follow NIDA on Twitter during XIX International AIDS Conference at @NIDAnews.

NIDA Press Office

About the National Institute on Drug Abuse (NIDA): The National Institute on Drug Abuse (NIDA) is a component of the National Institutes of Health, U.S. Department of Health and Human Services. NIDA supports most of the world’s research on the health aspects of drug use and addiction. The Institute carries out a large variety of programs to inform policy, improve practice, and advance addiction science. Fact sheets on the health effects of drugs and information on NIDA research and other activities can be found at www.drugabuse.gov, which is now compatible with your smartphone, iPad or tablet. To order publications in English or Spanish, call NIDA’s DrugPubs research dissemination center at 1-877-NIDA-NIH or 240-645-0228 (TDD) or email requests to drugpubs@nida.nih.gov. Online ordering is available at drugpubs.drugabuse.gov. NIDA’s media guide can be found at www.drugabuse.gov/publications/media-guide/dear-journalist, and its easy-to-read website can be found at www.easyread.drugabuse.gov. You can follow NIDA on Twitter and Facebook.

About the National Institutes of Health (NIH): NIH, the nation's medical research agency, includes 27 Institutes and Centers and is a component of the U.S. Department of Health and Human Services. NIH is the primary federal agency conducting and supporting basic, clinical, and translational medical research, and is investigating the causes, treatments, and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov.

NIH. . .Turning Discovery Into Health®

News Releases










Get this Publication

Cite this article

NIDA. (2012, July 18). NIDA Announces 2012 Avant-Garde Award for Medications Development. Retrieved from https://www.drugabuse.gov/news-events/news-releases/2012/07/nida-announces-2012-avant-garde-award-medications-development

press ctrl+c to copy
Receive Latest Science Articles in your Email!
You will only receive messages related to Latest Science